THE IMPACT-CABG TRIAL: A CANADIAN RCT OF CD133+ STEM CELL THERAPY FOR ISCHEMIC CARDIOMYOPATHY

Autor: Noiseux, N., Mansour, S., Weisel, R., Stevens, L., Tsang, K., Larose, E., Li, S., Spiller, N., Vu, M., Crean, A., Roy, D., Prieto, I., Li, R., Yau, T.
Zdroj: In Canadian Journal of Cardiology October 2015 31(10) Supplement:S76-S76
Databáze: ScienceDirect